Funding
Seed · Biotech

WonderTx records $125,000 seed financing from Y Combinator

AI models designed to discover oral medicines for diseases currently treated with injectable drugs.

Updated Oct 16, 2026By RoundOS Funding desk

WonderTx records $125,000 in seed financing from Y Combinator.

The company uses extrapolative models and experimental testing to discover oral drug candidates. It reports binder validation across four diverse targets, including crystallographic confirmation; the candidates remain in development.

Funding history

Seed · This round$125K

Sources

  1. WonderTx builds AI to replace injectable drugs with pills | Founderlandfounderland.ai · Sep 27, 2026
  2. startupdb.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related